- €262.40m
- €292.67m
- €36.03m
- 19
- 10
- 37
- 11
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS | PROSPECTUS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | IFRS | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 10.2 | 9.48 | 11.3 | 17.7 | 36 |
Cost of Revenue | |||||
Gross Profit | 3.04 | 2.11 | 2.97 | 5.32 | 12.7 |
Selling / General / Administrative Expenses | |||||
Depreciation and Amortization | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 9.58 | 9.45 | 11.9 | 20 | 39.4 |
Operating Profit | 0.624 | 0.027 | -0.611 | -2.29 | -3.4 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 0.479 | -0.118 | -0.748 | -2.52 | -4 |
Provision for Income Taxes | |||||
Net Income After Taxes | 0.318 | -0.093 | -0.7 | -1.99 | -3.08 |
Net Income Before Extraordinary Items | |||||
Net Income | 0.318 | -0.093 | -0.7 | -1.99 | -3.08 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 0.318 | -0.093 | -0.7 | -1.99 | -3.08 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.038 | -0.009 | -0.135 | -0.134 | -0.207 |
Dividends per Share |